HOME >> BIOLOGY >> NEWS
Columbia University awards 2006 Horwitz Prize to biologist who explained gene transcription

New York, NY October 4, 2006 Columbia University will award the 2006 Louisa Gross Horwitz Prize to structural biologist Roger D. Kornberg, Ph.D., Winzer Professor in Medicine at the Stanford School of Medicine. Dr. Kornberg will be honored for his work revolutionizing our understanding of gene transcription, the first step in transforming the genomic code in the cell into proteins, which run the cell.

It was also announced today that Dr. Kornberg has won the 2006 Nobel Prize in Chemistry.

"Dr. Kornberg's research is fundamental in pointing the way to innovative therapies for cancer, heart disease and other illnesses in which there is disturbance of genetic activity," said Lee Goldman, M.D., executive vice president of Columbia University and dean of the faculties of health sciences and medicine at Columbia University Medical Center. "His work represents exactly the type of scientific activity that we are proud to honor with the Horwitz Prize."

"We are pleased to continue our Horwitz tradition by awarding this year's prize to Roger Kornberg," said David Hirsh, Ph.D., executive vice president for research at Columbia University. "His groundbreaking work has been central to explaining the fundamental basis of gene regulation."

The Louisa Gross Horwitz Prize was established by Columbia University to recognize outstanding contributions to basic research in the fields of biology and biochemistry. Awarded annually since 1967, the prize was named for the mother of Columbia benefactor S. Gross Horwitz. Louisa Gross Horwitz was daughter of Dr. Samuel David Gross, author of "A System of Surgery" and a founder of the American Medical Association. For additional information about the Louisa Gross Horwitz Prize, visit: http://www.cumc.columbia.edu/horwitz.

"I'm pleased to receive this prestigious recognition, and am delighted to share the honor with some of the most distingu
'"/>

Contact: Craig LeMoult
cel2113@columbia.edu
212-305-0820
Columbia University Medical Center
4-Oct-2006


Page: 1 2 3

Related biology news :

1. Columbia University Medical Center awarded $3 million to drive Alzheimers genetics research
2. Columbia scientists determine 3-dimensional structure of cells fuel gauge
3. Columbia University licenses next-generation DNA sequencing technology
4. New bird discovered on unexplored Columbian mountain
5. Columbia University Medical Center receives major new NIH Clinical Science investment funds
6. Columbia University receives $16.9 million NIEHS award to study arsenic in ground water
7. Contaminants linked to sturgeon decline in Columbia river
8. Columbia University Medical Center researchers discover potential mechanism for tumor growth
9. UF, Columbia scientists closer to new cancer detection method
10. Columbia University awards 2005 Horwitz Prize to Israeli structural biologist
11. Columbia wins major grant to examine genetic link to Alzheimers Disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/1/2016)... , June 1, 2016 ... in Election Administration and Criminal Identification to Boost Global ... a recently released TechSci Research report, " Global Biometrics ... Region, Competition Forecast and Opportunities, 2011 - 2021", the ... billion by 2021, on account of growing security concerns ...
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
Breaking Biology Technology:
Cached News: